BioSpace News Archive

Program aims to enhance One Call’s individualized, holistic approach to helping injured workers regain health

Calvert Labs’ sponsorship will help connect LabCentral companies with Calvert’s senior scientists

Stoke Therapeuticss and research collaborators from the University of Michigan will present new preclinical data supporting Stoke’s development of its antisense oligonucleotide technology to treat Dravet Syndrome at the annual meeting of the American Epilepsy Society in New Orleans.

Bayer U.S. today announced the appointments of Albert J. Mitchell and Michael Parrish to two of the company’s corporate affairs leadership positions.

Swisslog Healthcare exhibits a broad portfolio of transport and pharmacy automation solutions for hospitals and health systems.

Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialization of personalized immunodiagnostics for the screening, detection and care of cancer, today announced that it has entered into an agreement with MultiPlan to expand access to Oncimmune’s EarlyCDT—Lung test.

Life Time, the premier healthy lifestyle brand, is set to open its newest luxury athletic club in Chicagoland in more than ten years.

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, reminds investors that a class action lawsuit has been filed against Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) and other defendants, related to alleged violations of federal securities laws.

AiPing Pharmaceutical, Inc. announced today that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd. AiPing will retain sales and distribution rights in the U.S.

“I am a gynecologist,” said an inventor from Sulphur Springs, Texas. “As a woman, I tried to figure out the worst part of this exam and how to improve the experience.